MicroRNAs: Exploring new horizons in osteoarthritis

Osteoarthritis and Cartilage

Volumn 24, Issue 4, 2016, Pages 573-580

  Nugent, M ^a  

^a Royal College of Surgeons in Ireland   (Ireland)

Author keywords

Cartilage; Chondrolysis; Inflammation; MicroRNA; MiRNA; Osteoarthritis

Indexed keywords

AGGRECANASE; COLLAGEN; COLLAGENASE 3; GROWTH FACTOR; INTERLEUKIN 1BETA; MICRORNA; MICRORNA 140; MICRORNA 27; MICRORNA 34A; MICRORNA 558; MICRORNA 602; MICRORNA 9; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG; AUTACOID; BIOLOGICAL MARKER; MIRN140 MICRORNA, HUMAN; MIRN92 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ARTICULAR CARTILAGE; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; MOLECULARLY TARGETED THERAPY; OSTEOARTHRITIS; PAIN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RNA SYNTHESIS; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; SYMPTOM; BLOOD; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION; GENETICS; METABOLISM;

BIOMARKERS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION MEDIATORS; MICRORNAS; OSTEOARTHRITIS; PAIN;

EID: 84960463010     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2015.10.018     Document Type: Review

References (110)

1. Goldring M.B., Otero M. Inflammation in osteoarthritis. Curr Opin Rheumatol 2011, 23(5):471-478.
2. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75(5):843-854.
3. miRBase 21 2014, University of Manchester, Manchester. 21st edn.
4. Kozomara A., Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011, 39(Database issue):D152-D157.
5. Kozomara A., Griffiths-Jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 2014, 42(Database issue):D68-D73.
6. Griffiths-Jones S. The microRNA registry. Nucleic Acids Res 2004, 32(Database issue):D109-D111.
7. Griffiths-Jones S., Saini H.K., van Dongen S., Enright A.J. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008, 36(Database issue):D154-D158.
8. Griffiths-Jones S., Grocock R.J., van Dongen S., Bateman A., Enright A.J. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006, 34(Database issue):D140-D144.
9. Ambros V., Bartel B., Bartel D.P., Burge C.B., Carrington J.C., Chen X., et al. A uniform system for microRNA annotation. RNA 2003, 9(3):277-279.
10. He L., Hannon G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004, 5(7):522-531.
11. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(2):281-297.
12. Li M., Marin-Muller C., Bharadwaj U., Chow K.H., Yao Q., Chen C. MicroRNAs: control and loss of control in human physiology and disease. World J Surg 2009, 33(4):667-684.
13. Slaby O., Svoboda M., Michalek J., Vyzula R. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer 2009, 8:102.
14. Wijnhoven B.P., Michael M.Z., Watson D.I. MicroRNAs and cancer. Br J Surg 2007, 94(1):23-30.
15. Faber C., Kirchner T., Hlubek F. The impact of microRNAs on colorectal cancer. Virchows Arch 2009, 454(4):359-367.
16. Rossi S., Kopetz S., Davuluri R., Hamilton S.R., Calin G.A. MicroRNAs, ultraconserved genes and colorectal cancers. Int J Biochem Cell Biol 2010 Aug, 42(8):1291-1297. [Epub 2009 Jun 2].
17. Cummins J.M., Velculescu V.E. Implications of micro-RNA profiling for cancer diagnosis. Oncogene 2006, 25(46):6220-6227.
18. Bandres E., Agirre X., Bitarte N., Ramirez N., Zarate R., Roman-Gomez J., et al. Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer 2009, 125:2737-2743.
19. Liu X., Chen X., Yu X., Tao Y., Bode A.M., Dong Z., et al. Regulation of microRNAs by epigenetics and their interplay involved in cancer. J Exp Clin Cancer Res 2013, 32(1):96.
20. Xi Y., Shalgi R., Fodstad O., Pilpel Y., Ju J. Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin Cancer Res 2006, 12(7 Pt 1):2014-2024.
21. Wark A.W., Lee H.J., Corn R.M. Multiplexed detection methods for profiling microRNA expression in biological samples. Angew Chem Int Ed Engl 2008, 47(4):644-652.
22. Kloosterman W.P., Wienholds E., de Bruijn E., Kauppinen S., Plasterk R.H. In situ detection of miRNAs in animal embryos using LNA-modified oligonucleotide probes. Nat Methods 2006, 3(1):27-29.
23. Castoldi M., Schmidt S., Benes V., Hentze M.W., Muckenthaler M.U. miChip: an array-based method for microRNA expression profiling using locked nucleic acid capture probes. Nat Protoc 2008, 3(2):321-329.
24. Castoldi M., Schmidt S., Benes V., Noerholm M., Kulozik A.E., Hentze M.W., et al. A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA). RNA 2006, 12(5):913-920.
25. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435(7043):834-838.
26. Kheirelseid EAH M.N., Chang K.H., Newell J., Kerin M.J. Identification of endogenous control genes for normalisation of real-time quantitative PCR data in colorectal cancer. BMC Mol Biol 2010 Feb 1, 11:12.
27. Chang K.H., Mestdagh P., Vandesompele J., Kerin M.J., Miller N. MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer. BMC Cancer 2010, 10:173.
28. Pritchard C.C., Cheng H.H., Tewari M. MicroRNA profiling: approaches and considerations. Nat Rev Genet 2012, 13(5):358-369.
29. Lopez J.P., Diallo A., Cruceanu C., Fiori L.M., Laboissiere S., Guillet I., et al. Biomarker discovery: quantification of microRNAs and other small non-coding RNAs using next generation sequencing. BMC Med Genomics 2015, 8:35.
30. Roberts B.S., Hardigan A.A., Kirby M.K., Fitz-Gerald M.B., Wilcox C.M., Kimberly R.P., et al. Blocking of targeted microRNAs from next-generation sequencing libraries. Nucleic Acids Res 2015 Jul 23, [Epub ahead of print].
31. Meng W., McElroy J.P., Volinia S., Palatini J., Warner S., Ayers L.W., et al. Comparison of microRNA deep sequencing of matched formalin-fixed paraffin-embedded and fresh frozen cancer tissues. PLoS One 2013, 8(5):e64393.
32. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008, 105(30):10513-10518.
33. Peter M.E. Targeting of mRNAs by multiple miRNAs: the next step. Oncogene 2010, 29(15):2161-2164.
34. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136(2):215-233.
35. Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., Burge C.B. Prediction of mammalian microRNA targets. Cell 2003, 115(7):787-798.
36. Krek A., Grun D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., et al. Combinatorial microRNA target predictions. Nat Genet 2005, 37(5):495-500.
37. Reczko M., Maragkakis M., Alexiou P., Grosse I., Hatzigeorgiou A.G. Functional microRNA targets in protein coding sequences. Bioinformatics 2012, 28(6):771-776.
38. Betel D., Wilson M., Gabow A., Marks D.S., Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res 2008, 36(Database issue):D149-D153.
39. Kruger J., Rehmsmeier M. RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res 2006, 34(Web Server issue):W451-W454.
40. Bandyopadhyay S., Mitra R. TargetMiner: microRNA target prediction with systematic identification of tissue-specific negative examples. Bioinformatics 2009, 25(20):2625-2631.
41. Xu W., San Lucas A., Wang Z., Liu Y. Identifying microRNA targets in different gene regions. BMC Bioinformatics 2014, 15(Suppl 7):S4.
42. Imig J., Brunschweiger A., Brummer A., Guennewig B., Mittal N., Kishore S., et al. miR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction. Nat Chem Biol 2015, 11(2):107-114.
43. Jaskiewicz L., Bilen B., Hausser J., Zavolan M. Argonaute CLIP-a method to identify in vivo targets of miRNAs. Methods 2012, 58(2):106-112.
44. Chou C.H., Lin F.M., Chou M.T., Hsu S.D., Chang T.H., Weng S.L., et al. A computational approach for identifying microRNA-target interactions using high-throughput CLIP and PAR-CLIP sequencing. BMC Genomics 2013, 14(Suppl 1):S2.
45. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002, 99(24):15524-15529.
46. Guay C., Regazzi R. MicroRNAs and the functional beta cell mass: for better or worse. Diabetes Metab 2015 Nov, 41(5):369-377.
47. Pua H.H., Ansel K.M. MicroRNA regulation of allergic inflammation and asthma. Curr Opin Immunol 2015, 36:101-108.
48. Nugent M., Miller N., Kerin M.J. MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers. Eur J Surg Oncol 2011, 37(8):649-654.
49. Nugent M. MicroRNA function and dysregulation in bone tumors: the evidence to date. Cancer Manag Res 2014, 6:15-25.
50. Notari M., Pulecio J., Raya A. Update on the pathogenic implications and clinical potential of microRNAs in cardiac disease. Biomed Res Int 2015, 2015:105620.
51. Henshall D.C. MicroRNA and epilepsy: profiling, functions and potential clinical applications. Curr Opin Neurol 2014, 27(2):199-205.
52. Kapoor M., Martel-Pelletier J., Lajeunesse D., Pelletier J.P., Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2011, 7(1):33-42.
53. Sekiya I., Tsuji K., Koopman P., Watanabe H., Yamada Y., Shinomiya K., et al. SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J Biol Chem 2000, 275(15):10738-10744.
54. Lefebvre V., Huang W., Harley V.R., Goodfellow P.N., de Crombrugghe B. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 1997, 17(4):2336-2346.
55. Knauper V., Lopez-Otin C., Smith B., Knight G., Murphy G. Biochemical characterization of human collagenase-3. J Biol Chem 1996, 271(3):1544-1550.
56. Knauper V., Cowell S., Smith B., Lopez-Otin C., O'Shea M., Morris H., et al. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem 1997, 272(12):7608-7616.
57. Fosang A.J., Last K., Knauper V., Murphy G., Neame P.J. Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett 1996, 380(1-2):17-20.
58. Jones S.W., Watkins G., Le Good N., Roberts S., Murphy C.L., Brockbank S.M., et al. The identification of differentially expressed microRNA in osteoarthritic tissue that modulate the production of TNF-alpha and MMP13. Osteoarthritis Cartilage 2009, 17(4):464-472.
59. Song J., Kim D., Chun C.H., Jin E.J. MicroRNA-9 regulates survival of chondroblasts and cartilage integrity by targeting protogenin. Cell Commun Signal 2013, 11:66.
60. Makki M.S., Haseeb A., Haqqi T.M. MicroRNA-9 promotes IL-6 expression by inhibiting MCPIP1 expression in IL-1beta-stimulated human chondrocytes. Arthritis Rheumatol 2015 May, 67(8):2117-2128.
61. Barter M.J., Bui C., Young D.A. Epigenetic mechanisms in cartilage and osteoarthritis: DNA methylation, histone modifications and microRNAs. Osteoarthritis Cartilage 2012, 20(5):339-349.
62. Borgonio Cuadra V.M., Gonzalez-Huerta N.C., Romero-Cordoba S., Hidalgo-Miranda A., Miranda-Duarte A. Altered expression of circulating microRNA in plasma of patients with primary osteoarthritis and in silico analysis of their pathways. PLoS One 2014, 9(6):e97690.
63. Park S.J., Cheon E.J., Lee M.H., Kim H.A. MicroRNA-127-5p regulates matrix metalloproteinase 13 expression and interleukin-1beta-induced catabolic effects in human chondrocytes. Arthritis Rheum 2013, 65(12):3141-3152.
64. Zhang Y., Jia J., Yang S., Liu X., Ye S., Tian H. MicroRNA-21 controls the development of osteoarthritis by targeting GDF-5 in chondrocytes. Exp Mol Med 2014, 46:e79.
65. Miyaki S., Nakasa T., Otsuki S., Grogan S.P., Higashiyama R., Inoue A., et al. MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum 2009, 60(9):2723-2730.
66. Tardif G., Hum D., Pelletier J.P., Duval N., Martel-Pelletier J. Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes. BMC Musculoskelet Disord 2009, 10:148.
67. Vonk L.A., Kragten A.H., Dhert W.J., Saris D.B., Creemers L.B. Overexpression of hsa-miR-148a promotes cartilage production and inhibits cartilage degradation by osteoarthritic chondrocytes. Osteoarthritis Cartilage 2014, 22(1):145-153.
68. Diaz-Prado S., Cicione C., Muinos-Lopez E., Hermida-Gomez T., Oreiro N., Fernandez-Lopez C., et al. Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytes. BMC Musculoskelet Disord 2012, 13:144.
69. Santini P., Politi L., Vedova P.D., Scandurra R., Scotto d'Abusco A. The inflammatory circuitry of miR-149 as a pathological mechanism in osteoarthritis. Rheumatol Int 2014, 34(5):711-716.
70. Zhang D., Cao X., Li J., Zhao G. MiR-210 inhibits NF-kappaB signaling pathway by targeting DR6 in osteoarthritis. Sci Rep 2015, 5:12775.
71. Kostopoulou F., Malizos K.N., Papathanasiou I., Tsezou A. MicroRNA-33a regulates cholesterol synthesis and cholesterol efflux-related genes in osteoarthritic chondrocytes. Arthritis Res Ther 2015, 17(1):42.
72. Song J., Kim D., Lee C.H., Lee M.S., Chun C.H., Jin E.J. MicroRNA-488 regulates zinc transporter SLC39A8/ZIP8 during pathogenesis of osteoarthritis. J Biomed Sci 2013, 20:31.
73. Park S.J., Cheon E.J., Kim H.A. MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1beta-induced catabolic effects in human articular chondrocytes. Osteoarthritis Cartilage 2013, 21(7):981-989.
74. Yang B., Kang X., Xing Y., Dou C., Kang F., Li J., et al. Effect of microRNA-145 on IL-1beta-induced cartilage degradation in human chondrocytes. FEBS Lett 2014, 588(14):2344-2352.
75. Li J., Huang J., Dai L., Yu D., Chen Q., Zhang X., et al. miR-146a, an IL-1beta responsive miRNA, induces vascular endothelial growth factor and chondrocyte apoptosis by targeting Smad4. Arthritis Res Ther 2012, 14(2):R75.
76. Jin L., Zhao J., Jing W., Yan S., Wang X., Xiao C., et al. Role of miR-146a in human chondrocyte apoptosis in response to mechanical pressure injury in vitro. Int J Mol Med 2014, 34(2):451-463.
77. Wang J.H., Shih K.S., Wu Y.W., Wang A.W., Yang C.R. Histone deacetylase inhibitors increase microRNA-146a expression and enhance negative regulation of interleukin-1beta signaling in osteoarthritis fibroblast-like synoviocytes. Osteoarthritis Cartilage 2013, 21(12):1987-1996.
78. Song J., Lee M., Kim D., Han J., Chun C.H., Jin E.J. MicroRNA-181b regulates articular chondrocytes differentiation and cartilage integrity. Biochem Biophys Res Commun 2013, 431(2):210-214.
79. Swingler T.E., Wheeler G., Carmont V., Elliott H.R., Barter M.J., Abu-Elmagd M., et al. The expression and function of microRNAs in chondrogenesis and osteoarthritis. Arthritis Rheum 2012, 64(6):1909-1919.
80. Min Z., Zhang R., Yao J., Jiang C., Guo Y., Cong F., et al. MicroRNAs associated with osteoarthritis differently expressed in bone matrix gelatin (BMG) rat model. Int J Clin Exp Med 2015, 8(1):1009-1017.
81. Araldi E., Schipani E. MicroRNA-140 and the silencing of osteoarthritis. Genes Dev 2010, 24(11):1075-1080.
82. Miyaki S., Asahara H. Macro view of microRNA function in osteoarthritis. Nat Rev Rheumatol 2012, 8(9):543-552.
83. Miyaki S., Sato T., Inoue A., Otsuki S., Ito Y., Yokoyama S., et al. MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev 2010, 24(11):1173-1185.
84. Liang Z.J., Zhuang H., Wang G.X., Li Z., Zhang H.T., Yu T.Q., et al. MiRNA-140 is a negative feedback regulator of MMP-13 in IL-1beta-stimulated human articular chondrocyte C28/I2 cells. Inflamm Res 2012, 61(5):503-509.
85. Akhtar N., Rasheed Z., Ramamurthy S., Anbazhagan A.N., Voss F.R., Haqqi T.M. MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. Arthritis Rheum 2010, 62(5):1361-1371.
86. Nugent M., Miller N., Kerin M.J. Circulating miR-34a levels are reduced in colorectal cancer. J Surg Oncol 2012, 106(8):947-952.
87. Blanco F.J., Ochs R.L., Schwarz H., Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 1995, 146(1):75-85.
88. Abouheif M.M., Nakasa T., Shibuya H., Niimoto T., Kongcharoensombat W., Ochi M. Silencing microRNA-34a inhibits chondrocyte apoptosis in a rat osteoarthritis model in vitro. Rheumatology (Oxford) 2010, 49(11):2054-2060.
89. Dai L., Zhang X., Hu X., Zhou C., Ao Y. Silencing of microRNA-101 prevents IL-1beta-induced extracellular matrix degradation in chondrocytes. Arthritis Res Ther 2012, 14(6):R268.
90. Martinez-Sanchez A., Dudek K.A., Murphy C.L. Regulation of human chondrocyte function through direct inhibition of cartilage master regulator SOX9 by microRNA-145 (miRNA-145). J Biol Chem 2012, 287(2):916-924.
91. Akhtar N., Makki M.S., Haqqi T.M. MicroRNA-602 and microRNA-608 regulate sonic hedgehog expression via target sites in the coding region in human chondrocytes. Arthritis Rheumatol 2015, 67(2):423-434.
92. Lin A.C., Seeto B.L., Bartoszko J.M., Khoury M.A., Whetstone H., Ho L., et al. Modulating hedgehog signaling can attenuate the severity of osteoarthritis. Nat Med 2009, 15(12):1421-1425.
93. Naito S., Shiomi T., Okada A., Kimura T., Chijiiwa M., Fujita Y., et al. Expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic cartilage. Pathol Int 2007, 57(11):703-711.
94. Song R.H., Tortorella M.D., Malfait A.M., Alston J.T., Yang Z., Arner E.C., et al. Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5. Arthritis Rheum 2007, 56(2):575-585.
95. Matsukawa T., Sakai T., Yonezawa T., Hiraiwa H., Hamada T., Nakashima M., et al. MicroRNA-125b regulates the expression of aggrecanase-1 (ADAMTS-4) in human osteoarthritic chondrocytes. Arthritis Res Ther 2013, 15(1):R28.
96. Kim J.H., Kim S.J. Overexpression of microRNA-25 by withaferin A induces cyclooxygenase-2 expression in rabbit articular chondrocytes. J Pharmacol Sci 2014, 125(1):83-90.
97. Li X., Gibson G., Kim J.S., Kroin J., Xu S., van Wijnen A.J., et al. MicroRNA-146a is linked to pain-related pathophysiology of osteoarthritis. Gene 2011, 480(1-2):34-41.
98. Zhong N., Sun J., Min Z., Zhao W., Zhang R., Wang W., et al. MicroRNA-337 is associated with chondrogenesis through regulating TGFBR2 expression. Osteoarthritis Cartilage 2012, 20(6):593-602.
99. Yamasaki K., Nakasa T., Miyaki S., Ishikawa M., Deie M., Adachi N., et al. Expression of MicroRNA-146a in osteoarthritis cartilage. Arthritis Rheum 2009, 60(4):1035-1041.
100. Li X., Kroin J.S., Kc R., Gibson G., Chen D., Corbett G.T., et al. Altered spinal microRNA-146a and the microRNA-183 cluster contribute to osteoarthritic pain in knee joints. J Bone Miner Res 2013, 28(12):2512-2522.
101. Heneghan H.M., Miller N., Lowery A.J., Sweeney K.J., Newell J., Kerin M.J. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 2010 Mar, 251(3):499-505.
102. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008, 18(10):997-1006.
103. Murata K., Yoshitomi H., Tanida S., Ishikawa M., Nishitani K., Ito H., et al. Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis. Arthritis Res Ther 2010, 12(3):R86.
104. Okuhara A., Nakasa T., Shibuya H., Niimoto T., Adachi N., Deie M., et al. Changes in microRNA expression in peripheral mononuclear cells according to the progression of osteoarthritis. Mod Rheumatol 2012, 22(3):446-457.
105. Beyer C., Zampetaki A., Lin N.Y., Kleyer A., Perricone C., Iagnocco A., et al. Signature of circulating microRNAs in osteoarthritis. Ann Rheum Dis 2015, 74(3):e18.
106. Gougelet A., Pissaloux D., Besse A., Perez J., Duc A., Dutour A., et al. Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response. Int J Cancer 2011, 129(3):680-690.
107. Zhao G., Cai C., Yang T., Qiu X., Liao B., Li W., et al. MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma. PLoS One 2013, 8(1):e53906.
108. Nagata Y., Nakasa T., Mochizuki Y., Ishikawa M., Miyaki S., Shibuya H., et al. Induction of apoptosis in the synovium of mice with autoantibody-mediated arthritis by the intraarticular injection of double-stranded MicroRNA-15a. Arthritis Rheum 2009, 60(9):2677-2683.
109. Wiggins J.F., Ruffino L., Kelnar K., Omotola M., Patrawala L., Brown D., et al. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res 2010, 70(14):5923-5930.
110. Lanford R.E., Hildebrandt-Eriksen E.S., Petri A., Persson R., Lindow M., Munk M.E., et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010, 327(5962):198-201.